sacituzumab govitecan

A drug used to treat adults with triple-negative breast cancer that has spread to other parts of the body. It is used in patients who have received at least two other therapies for metastatic disease. It is also being studied in the treatment of other types of cancer. Sacituzumab govitecan contains a monoclonal antibody called sacituzumab that binds to a protein called TROP2, which is found on some breast cancer cells. It also contains an anticancer drug called SN-38, which may help kill cancer cells. Sacituzumab govitecan is a type of antibody-drug conjugate. Also called Trodelvy.